$240,536
＋20.1%
Co-Executive Director
2024
$234k
40 hrs/wk
$8k
--
Co-Executive Director at Epilepsy Study Consortium Inc.
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Bree Diventura has been listed as an employee of Epilepsy Study Consortium Inc. in Form 990 filings since at least fiscal year 2016. Total compensation for Bree Diventura has increased by 96.3% from 2016 to 2024.